Gates urges more tools, vaccine to end AIDS
AIDS cannot be halted through treatment alone, and more prevention tools, in particular a vaccine, are needed to move seriously toward ending it, philanthropist Bill Gates said Monday.
While the Microsoft tycoon applauded efforts to get more people worldwide on antiretroviral drugs -- and said his foundation funds both research and care -- he noted more is needed to stamp out the deadly disease.
"No one should think that we have got the tools yet. We will get the tools but only if we stay the course in terms of the scientific investments," Gates told the International AIDS Conference in the US capital.
His Bill & Melinda Gates Foundation has committed more than $2.5 billion in HIV grants to organizations around the world, and has also committed more than $1.4 billion to the Global Fund to Fight AIDS, Tuberculosis and Malaria.
Gates spoke to the conference, the world's largest gathering of AIDS scientists and advocates, as part of a panel on how to improve efficiency in funding of the three-decade-old disease that has killed 30 million people.
Gates said research toward a vaccine is "very exciting" but noted that even if a vaccine were introduced it would take time before the effects would be seen in the larger population.
"If you get a vaccine say in 10 years then the number of people you need to put on treatment is reduced in about 18 years," he said.
"Unfortunately there is this unbelievable lag time that comes out of that."
More than eight million people in low and middle income countries were on antiretroviral treatment in 2011 according to a UNAIDS report released last week, making up about half of those in need worldwide.
But Gates warned that no amount of funding can come up with enough money to treat everyone infected.
"It is clear that even if you take the most efficient way of doing this work -- the number of people who will eventually need to be on treatment, the amount of money we have is not enough to treat those people," he said.
"The world will make a decision how much those lives matter. And we are in a period of incredible uncertainty right now," he added.
"Just the uncertainty alone creates a certain instability."
Gates urged continued involvement by the AIDS community and reiterated the importance for nations and donors to support research, but also expressed support for ongoing treatment initiatives in the meantime.
"Now if somebody could cure AIDS -- which unfortunately that's very much a long shot," he said.
"There are people who are working it but... it is not in the cards at least any time soon, that is why this treatment imperative is so dramatic."
(c) 2012 AFP
- AIDS charity honors Gates on eve of global conference Jul 22, 2012 | not rated yet | 0
- Bill Clinton, Gates: Fight AIDS more efficiently Jul 19, 2010 | not rated yet | 0
- $15M allocated to AIDS vaccine research Aug 02, 2007 | not rated yet | 0
- Gates: $258 million for malaria research Oct 31, 2005 | not rated yet | 0
- US donates extra $150 million to battle AIDS Jul 23, 2012 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Classical and Quantum Mechanics via Lie algebras
Apr 15, 2011 I'd like to open a discussion thread for version 2 of the draft of my book ''Classical and Quantum Mechanics via Lie algebras'', available online at http://lanl.arxiv.org/abs/0810.1019 , and for the...
- More from Physics Forums - Independent Research
More news stories
(AP)—The decade-old law that transformed the battle against HIV and AIDS in developing countries is at a crossroads. The dream of future generations freed from the epidemic is running up against an era ...
HIV & AIDS 5 hours ago | not rated yet | 0
The hunt for an HIV vaccine has gobbled up $8 billion in the past decade, and the failure of the most recent efficacy trial has delivered yet another setback to 26 years of efforts.
HIV & AIDS May 19, 2013 | 5 / 5 (1) | 0
Big names in medicine are set to give an upbeat assessment of the war on AIDS on Tuesday, 30 years after French researchers identified the virus that causes the disease.
HIV & AIDS May 18, 2013 | 5 / 5 (2) | 0
Researchers at the University of Cincinnati (UC) have found that incorporating a peer-referral program for HIV testing into emergency departments can reach new groups of high-risk patients and brings more patients into the ...
HIV & AIDS May 17, 2013 | not rated yet | 0
(HealthDay)—Liver transplants to treat a common type of liver cancer are a viable option for people infected with HIV, according to new research.
HIV & AIDS May 17, 2013 | not rated yet | 0
In a remote fishing community in Venezuela, a lone fisherman sits on a cliff overlooking the southern Caribbean Sea. This man –– the lookout –– is responsible for directing his comrades on the water, ...
43 minutes ago | not rated yet | 0 |
A novel approach to obstructing the runaway inflammatory response implicated in some types of asthma has shown promise in a Phase IIa clinical trial, according to U. S. researchers.
37 minutes ago | not rated yet | 0
Authorities are investigating rice mills in southern China following tests that found almost half of the staple grain in one of the country's largest cities was contaminated with a toxic metal.
42 minutes ago | not rated yet | 0
Scientists from Nanyang Technological University (NTU) and Lund University, Sweden, have bioengineered a novel molecule which has been proven to successfully kill tumour cells.
52 minutes ago | not rated yet | 0
Clinical measurement of physical activity appears to be an independent predictor of whether or not patients with chronic obstructive pulmonary disease (COPD) will end up being hospitalized, according to a new study conducted ...
22 minutes ago | not rated yet | 0
Delayed transfer to the intensive care unit (ICU) in hospitalized patients significantly increases the risk of dying in the hospital, according to a new study from researchers in Chicago.
2 minutes ago | not rated yet | 0